在患有无形性贫血和粘性菌根症的淋巴缺血患者中,用INTERLEUKIN-7进行免疫辅助疗法
Zachary D Crees1, Dilan A Patel1, Alexandra Dram2
1Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
Critical care explorations
|October 23, 2023
概括
患有侵入性真菌感染的无形性贫血患者可能从免疫辅助疗法中受益. 干白素-7 (IL-7) 治疗使淋巴细胞数量正常化,并在一例中清除了真菌病原体.
科学领域:
- 免疫学 免疫学 免疫学
- 菌类学 菌类学是指菌类学.
- 血液学 血液学 血液学
背景情况:
- 无形性贫血和泛细胞衰竭通常需要免疫抑制疗法.
- 患者可能会患上严重的机会性感染,如粘膜菌.
- 标准的抗真菌治疗在严重免疫损害的个体中可能不足.
研究的目的:
- 为了研究免疫辅助疗法的有效性,在一个患有无塑性贫血和侵袭性肺粘膜菌的患者.
- 评价介素-7 (IL-7) 作为免疫辅助剂在治疗耐火性真菌感染中的作用.
主要方法:
- 该研究报告说,一名患有无形成性贫血的患者接受了免疫抑制疗法.
- 患者患有侵袭性肺粘菌,并用双抗真菌药物治疗.
- 由于严重的淋巴缺血和疾病进展,尽管接受了标准治疗,Interleukin-7 (IL-7) 仍在使用.
主要成果:
- 干白素-7 (IL-7) 的使用导致了绝对淋巴细胞数的正常化.
- 用IL-7治疗暂时与真菌病原体的清除有关.
- 临床症状在IL-7治疗后消失,表明治疗有效性.
结论:
- 在免疫抑制患者中,应考虑免疫辅助疗法,包括IL-7,用于危及生命的真菌感染,这些患者对标准抗真菌治疗没有反应.
- 由于其广泛的免疫效应增强抗真菌免疫力,IL-7显示出作为免疫辅助剂的潜力.
- 需要进一步进行严格的临床试验,以确定免疫辅助剂在治疗侵入性真菌感染中的作用.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538